Women Health Diagnostics Market Size

Women Health Diagnostics Market size was valued at USD 18.63 billion in 2023 and is likely to cross USD 46 billion by the end of 2036, expanding at more than 7.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of women health diagnostics is assessed at USD 19.7 billion.

The growth of the market can be attributed to the rising awareness levels about various health disorders across the globe, and increasing prevalence of lifestyle and chronic diseases among women. According to the Pan American Health Organization, in 2019, a total of 534,242 deaths occurred due to chronic respiratory diseases in the region of the Americas alone, out of which 266,725, i.e., 50 percent deaths were among women. Along with these, growing occurrence of infectious disorders such as hepatitis and HIV in women all around the world is also expected to boost the growth of the market significantly in the forthcoming years. Furthermore, since the past few years, immunoassays, a highly popular platforms for diagnosing several conditions among women, are receiving surge in the number of regulatory approvals from medical bodies worldwide. This in turn is projected to offer ample growth opportunities to the market in the near future.